Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Helicobacter pylori and immunotherapy for gastrointestinal cancer
Keren Jia, Chen Yang, Yi Xie, et al.
The Innovation (2024) Vol. 5, Iss. 2, pp. 100561-100561
Open Access | Times Cited: 24

Showing 24 citing articles:

Stomach microbiota in gastric cancer development and clinical implications
Ruijie Zeng, Hongyan Gou, Harry Cheuk-Hay Lau, et al.
Gut (2024), pp. gutjnl-332815
Open Access | Times Cited: 23
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 15
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
Jiawei Song, Jun Zhu, Yu Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189277-189277
Closed Access | Times Cited: 1
Advancing precision oncology: Insights into the tumor microenvironment and immunotherapy outcomes
Tomotaka Ugai, Qian Yao, Satoko Ugai, et al.
The Innovation (2024) Vol. 5, Iss. 4, pp. 100656-100656
Open Access | Times Cited: 7
Exploring food and medicine homology: potential implications for cancer treatment innovations
Mengyao Li, Ao Gu, Jiatong Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access
Novel Therapeutic Strategies and Recent Advances in Gut Microbiota Synergy with Nanotechnology for Colorectal Cancer Treatment
Qinghe Han, Jie Li, Zhuo Li, et al.
Materials Today Bio (2025) Vol. 31, pp. 101601-101601
Open Access
Nanoparticle-based Traditional Chinese Medicine for Immunotherapy in Gastrointestinal Tumors
Linjia Peng, Yan‐Feng Liang, Qiuli Zhang, et al.
Nano Biomedicine and Engineering (2025)
Open Access
Helicobacter pylori and Colorectal Cancer: Meeting Sir Austin Bradford Hill's Causality Criteria
Juan Sebastián Frías‐Ordoñez, Arnoldo Riquelme, Hernando Marulanda Fernández, et al.
Helicobacter (2025) Vol. 30, Iss. 2
Closed Access
Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence
Tessa S. Groen-van Schooten, Manuel Cabeza-Segura, Rui M. Ferreira, et al.
British Journal of Cancer (2025)
Open Access
Predictive biomarkers for immunotherapy in gastric cancer
Sijia Li, Huayuan Liang, Guoxin Li
Journal of Cancer Metastasis and Treatment (2025)
Open Access
Efficacy and safety of sintilimab combined with trastuzumab and chemotherapy in HER2-positive advanced gastric or gastroesophageal junction cancer
Zeyu Liu, Aina Liu, Ming Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The enigma of maladaptation in gastric pathophysiology
Gunter Maubach, Anumantha G. Kanthasamy, Sudhanshu Gogia, et al.
Trends in cancer (2025)
Open Access
Impact of Helicobacter pylori infection status on outcomes among patients with gastric cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Francisco Cézar Aquino de Moraes, Luis Eduardo Rodrigues Sobreira, Francinny Alves Kelly, et al.
Microbial Pathogenesis (2025), pp. 107407-107407
Closed Access
Effect of Helicobacter Pylori infection on immunotherapy for gastrointestinal cancer: a narrative review
Afroditi Ziogou, Alexios Giannakodimos, Ilias Giannakodimos, et al.
Immunotherapy (2025), pp. 1-14
Closed Access
Relationship between Helicobacter pylori infection and programmed death-ligand 1 in gastric cancer: A meta-analysis
Hong-Chang Yang, Chunhua Fu, Lijun Qiao, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
Helicobacter pylori Infection in Patients with Gastric Cancer: A 2024 Update
Claudia Burz, Vlad Pop, Ciprian Silaghi, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1958-1958
Open Access | Times Cited: 2
Single‐cell characterization of differentiation trajectories and drug resistance features in gastric cancer with peritoneal metastasis
Haoxin Peng, Lei Jiang, Jiajia Yuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 2
Impact ofHelicobacter pylorion immunotherapy in gastric cancer
Jing Li, Zongyin Wu, Rong Lin
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e010354-e010354
Open Access | Times Cited: 2
Weizmannia coagulans BC99 affects valeric acid production via regulating gut microbiota to ameliorate inflammation and oxidative stress responses in Helicobacter pylori mice
Shirui Zhai, Ying Gao, Yiru Jiang, et al.
Journal of Food Science (2024)
Closed Access | Times Cited: 2
Effects and mechanisms of Helicobacter pylori on cancers development and immunotherapy
Xiaotian Zhong, Huiling Zheng, Shiqing Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Gut microbiota in cancer initiation, development and therapy
Ruyi Zhang, Xiang Zhang, Harry Cheuk-Hay Lau, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 1
Characteristics, fate, and effects of <i>Helicobacter pylori</i> in municipal wastewater treatment plant
Ying Wang, Yunping Han, Wenwen Wang, et al.
The Innovation Geoscience (2024) Vol. 2, Iss. 3, pp. 100080-100080
Closed Access
A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 Update
Gabriel Samaşcă, Claudia Burz, Irena Pintea, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1121-1121
Open Access
Negative response to immunotherapy in dMMR or MSI-H gastric cancer with APC and PTEN mutations: a case report
Jiang Liu, Xiumei Zhang, Qun Ren, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top